Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments

@inproceedings{Campana2016FrequentOO,
  title={Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments},
  author={R. Delgado Campana and Katharina B Moritz and Katharina Marth and Angela Neubauer and Hans Huber and Rainer Dr. Henning and Katharina Blatt and Gregor Hoermann and Tess Melinda Brodie and Alexandra Kaider and Peter Valent and Federica Sallusto and Stefan W{\"o}hrl and Rudolf Valenta},
  booktitle={The Journal of allergy and clinical immunology},
  year={2016}
}
BACKGROUND Late allergic reactions are common in the course of allergen-specific immunotherapy and even occur with allergy vaccines with reduced IgE reactivity. OBJECTIVE We sought to study atopy patch test (APT) reactions and T-cell responses to the recombinant birch pollen allergen Bet v 1 and recombinant hypoallergenic T-cell epitope-containing Bet v 1 fragments in patients with birch pollen allergy with and without atopic dermatitis (AD). METHODS A clinical study was conducted in 15… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Antihistaminic Treatment, Allergen‐Specific Immunotherapy, and Blockade of IgE as Alternative Allergy Treatments

Olga Lima Tavares Machado, Débora Mothé de Campos‐Mesquita, Thais Pacheco‐Soares
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

Molecular aspects of allergens in atopic dermatitis

  • Current opinion in allergy and clinical immunology
  • 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives.

  • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2008